• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钆基磁共振造影剂在1.5、3和7特斯拉下于人体全血中的T1弛豫率

T1 relaxivities of gadolinium-based magnetic resonance contrast agents in human whole blood at 1.5, 3, and 7 T.

作者信息

Shen Yaqi, Goerner Frank L, Snyder Christopher, Morelli John N, Hao Dapeng, Hu Daoyu, Li Xiaoming, Runge Val M

机构信息

From the *Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, People's Republic of China; †Department of Radiology, University of Texas Medical Branch, Galveston; ‡Department of Pediatric Radiology, Texas Children's Hospital; §Department of Radiology, Baylor College of Medicine, Houston, TX; ∥The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University, Baltimore, MD; ¶Department of Radiology, The Affiliated Hospital of Medical College of Qingdao University, Qingdao, People's Republic of China; and #Institute for Diagnostic and Interventional Radiology, Clinics for Neuroradiology and Nuclear Medicine, University Hospital Zurich, Zurich, Switzerland.

出版信息

Invest Radiol. 2015 May;50(5):330-8. doi: 10.1097/RLI.0000000000000132.

DOI:10.1097/RLI.0000000000000132
PMID:25658049
Abstract

OBJECTIVES

Calculation of accurate T1 relaxivity (r1) values for gadolinium-based magnetic resonance contrast agents (GBCAs) is a complex process. As such, often referenced r1 values for the GBCAs at 1.5 T, 3 T, and 7 T are based on measurements obtained in media that are not clinically relevant, derived from only a small number of concentrations, or available for only a limited number of GBCAs. This study derives the r1 values of the 8 commercially available GBCAs in human whole blood at 1.5 T, 3 T, and 7 T.

MATERIALS AND METHODS

Eight GBCAs were serially diluted in human whole blood, at 7 concentrations from 0.0625 to 4 mM. A custom-built phantom held the dilutions in air-tight cylindrical tubes maintained at 37 ± 0.5°C by a heat-circulating system. Images were acquired using inversion recovery sequences with inversion times from 30 milliseconds to 10 seconds at 1.5 T and 3 T as well as 60 milliseconds to 5 seconds at 7 T. A custom MATLAB program was used to automate signal intensity measurements from the images acquired of the phantom. SigmaPlot was used to calculate T1 relaxation times and, finally, r1.

RESULTS

Measured r1 values in units of s⁻¹·mM⁻¹ at 1.5 T (3 T/7 T) were 3.9 ± 0.2 (3.4 ± 0.4/2.8 ± 0.4) for Gd-DOTA, 4.6 ± 0.2 (4.5 ± 0.3/4.2 ± 0.3) for Gd-DO3A-butrol, 4.3 ± 0.4 (3.8 ± 0.2/3.1 ± 0.4) for Gd-DTPA, 6.2 ± 0.5 (5.4 ± 0.3/4.7 ± 0.1) for Gd-BOPTA, 4.5 ± 0.1 (3.9 ± 0.2/3.7 ± 0.2) for Gd-DTPA-BMA, 4.4 ± 0.2 (4.2 ± 0.2/4.3 ± 0.2) for Gd-DTPA-BMEA, 7.2 ± 0.2 (5.5 ± 0.3/4.9 ± 0.1) for Gd-EOB-DTPA, and 4.4 ± 0.6 (3.5 ± 0.6/3.4 ± 0.1) for Gd-HP-DO3A. The agents can be stratified by relaxivity, with a significant additional dependency on field strength.

CONCLUSIONS

This report quantifies, for the first time, T1 relaxivity for all 8 gadolinium chelates in common clinical use worldwide, at current relevant field strengths, in human whole blood at physiological temperature (37°C). The measured r1 values differ to a small degree from previously published values, where such comparisons exist, with the current r1 measurements being that most relevant to clinical practice. The macrocyclic agents, with the exception of Gd-DO3A-butrol, have slightly lower r1 values when compared with the 2 much less stable linear agents, Gd-DTPA-BMA and Gd-DTPA-BMEA. The 2 agents with hepatobiliary excretion, Gd-EOB-DTPA and Gd-BOPTA, have, at 1.5 and 3 T, substantially higher r1 values than all other agents.

摘要

目的

计算钆基磁共振造影剂(GBCAs)准确的T1弛豫率(r1)值是一个复杂的过程。因此,常引用的1.5T、3T和7T时GBCAs的r1值是基于在与临床无关的介质中获得的测量结果,这些介质仅来自少数浓度,或者仅适用于有限数量的GBCAs。本研究得出了8种市售GBCAs在1.5T、3T和7T时人全血中的r1值。

材料与方法

将8种GBCAs在人全血中进行系列稀释,浓度范围为0.0625至4mM,共7个浓度。一个定制的体模将稀释液置于气密的圆柱形管中,通过热循环系统保持在37±0.5°C。使用反转恢复序列采集图像,1.5T和3T时反转时间为30毫秒至10秒,7T时为60毫秒至5秒。使用定制的MATLAB程序自动测量体模图像的信号强度。使用SigmaPlot计算T1弛豫时间,最后计算r1。

结果

1.5T(3T/7T)时以s⁻¹·mM⁻¹为单位的测量r1值,钆喷酸葡胺(Gd-DOTA)为3.9±0.2(3.4±0.4/2.8±0.4),钆布醇(Gd-DO3A-butrol)为4.6±0.2(4.5±0.3/4.2±0.3),钆双胺(Gd-DTPA)为4.3±0.4(3.8±0.2/3.1±0.4),钆贝葡胺(Gd-BOPTA)为6.2±0.5(5.4±0.3/4.7±0.1),钆特醇(Gd-DTPA-BMA)为4.5±0.1(3.9±0.2/3.7±0.2),钆大胺(Gd-DTPA-BMEA)为4.4±0.2(4.2±0.2/4.3±0.2),钆塞酸二钠(Gd-EOB-DTPA)为7.2±0.2(5.5±0.3/4.9±0.1),钆六醇(Gd-HP-DO3A)为4.4±0.6(3.5±0.6/3.4±0.1)。这些造影剂可根据弛豫率进行分层,并且对场强有显著的额外依赖性。

结论

本报告首次量化了全球范围内临床上常用的所有8种钆螯合物在当前相关场强下、生理温度(37°C)的人全血中的T1弛豫率。在有可比数据的情况下,测量得到的r1值与先前发表的值略有不同,当前的r1测量值与临床实践最为相关。大环类造影剂(钆布醇除外)与两种稳定性差得多的线性造影剂钆特醇和钆大胺相比,r1值略低。两种具有肝胆排泄功能的造影剂钆塞酸二钠和钆贝葡胺在1.5T和3T时的r1值明显高于所有其他造影剂。

相似文献

1
T1 relaxivities of gadolinium-based magnetic resonance contrast agents in human whole blood at 1.5, 3, and 7 T.钆基磁共振造影剂在1.5、3和7特斯拉下于人体全血中的T1弛豫率
Invest Radiol. 2015 May;50(5):330-8. doi: 10.1097/RLI.0000000000000132.
2
Relaxivity of Gadopentetate Dimeglumine (Magnevist), Gadobutrol (Gadovist), and Gadobenate Dimeglumine (MultiHance) in human blood plasma at 0.2, 1.5, and 3 Tesla.钆喷酸葡胺(马根维显)、钆布醇(佳迪显)和钆贝葡胺(多它灵)在人血浆中于0.2、1.5和3特斯拉时的弛豫率
Invest Radiol. 2006 Mar;41(3):213-21. doi: 10.1097/01.rli.0000197668.44926.f7.
3
Gadolinium Magnetic Resonance Imaging钆磁共振成像
4
Influence of human serum albumin on longitudinal and transverse relaxation rates (r1 and r2) of magnetic resonance contrast agents.人血清白蛋白对磁共振造影剂纵向和横向弛豫率(r1和r2)的影响。
Invest Radiol. 2006 Mar;41(3):222-8. doi: 10.1097/01.rli.0000192421.81037.d5.
5
In vitro T2 relaxivities of the Gd-based contrast agents (GBCAs) in human blood at 1.5 and 3 T.基于钆的造影剂(GBCAs)在1.5和3特斯拉磁场下于人体血液中的体外T2弛豫率
Acta Radiol. 2019 Jun;60(6):694-701. doi: 10.1177/0284185118799538. Epub 2018 Sep 11.
6
Delayed Gadolinium-enhanced MR Imaging of Cartilage: A Comparative Analysis of Different Gadolinium-based Contrast Agents in an ex Vivo Porcine Model.软骨磁共振增强延迟成像:一种基于钆的不同对比剂在体外猪模型中的比较分析。
Radiology. 2017 Mar;282(3):734-742. doi: 10.1148/radiol.2016160367. Epub 2016 Sep 20.
7
Tissue gadolinium deposition in renally impaired rats exposed to different gadolinium-based MRI contrast agents: evaluation with inductively coupled plasma mass spectrometry (ICP-MS).肾损伤大鼠暴露于不同钆基 MRI 对比剂后的组织钆沉积:电感耦合等离子体质谱法(ICP-MS)评估。
Magn Reson Imaging. 2013 Oct;31(8):1412-7. doi: 10.1016/j.mri.2013.03.025. Epub 2013 Apr 30.
8
A comparison of two MR hepatobiliary gadolinium chelates: Gd-BOPTA and Gd-EOB-DTPA.两种钆螯合物的比较:钆贝葡胺(Gd-BOPTA)和钆塞酸二钠(Gd-EOB-DTPA)。
J Comput Assist Tomogr. 1998 Jul-Aug;22(4):643-50. doi: 10.1097/00004728-199807000-00026.
9
Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging.应用动态对比增强磁共振成像进行药代动力学分析的钆对比剂的个体内体内比较。
Invest Radiol. 2010 May;45(5):233-44. doi: 10.1097/RLI.0b013e3181d54507.
10
Gadolinium-based magnetic resonance contrast agents at 7 Tesla: in vitro T1 relaxivities in human blood plasma.基于钆的磁共振对比剂在 7 特斯拉下:人血浆中的体外 T1 弛豫率。
Invest Radiol. 2010 Sep;45(9):554-8. doi: 10.1097/RLI.0b013e3181ebd4e3.

引用本文的文献

1
Identification and Characterization of a Translational Mouse Model for Blood-Brain Barrier Leakage in Cerebral Small Vessel Disease.脑小血管病血脑屏障渗漏的转化小鼠模型的鉴定与表征
Int J Mol Sci. 2025 Jul 12;26(14):6706. doi: 10.3390/ijms26146706.
2
Pilot study on indirect magnetic resonance lymphography using gadoxetate disodium in dogs.使用钆塞酸二钠对犬进行间接磁共振淋巴造影的初步研究。
J Vet Med Sci. 2025 Aug 1;87(8):898-901. doi: 10.1292/jvms.25-0166. Epub 2025 Jun 10.
3
The diagnostic value of advanced tracer kinetic models in evaluating high grade gliomas recurrence and treatment response using dynamic contrast-enhanced MRI.
先进示踪剂动力学模型在利用动态对比增强磁共振成像评估高级别胶质瘤复发及治疗反应中的诊断价值
Front Oncol. 2025 Apr 16;15:1536122. doi: 10.3389/fonc.2025.1536122. eCollection 2025.
4
Binuclear Lanthanide Complexes as Magnetic Resonance and Optical Imaging Probes for Redox Sensing.双核镧系配合物作为用于氧化还原传感的磁共振和光学成像探针
Chemistry. 2025 May 27;31(30):e202404748. doi: 10.1002/chem.202404748. Epub 2025 May 3.
5
Identifying new therapeutics for focused ultrasound-enhanced drug delivery in the management of glioblastoma.确定用于胶质母细胞瘤治疗中聚焦超声增强药物递送的新疗法。
Front Oncol. 2025 Mar 13;15:1507940. doi: 10.3389/fonc.2025.1507940. eCollection 2025.
6
A novel protein for bioremediation of gadolinium waste.一种用于钆废物生物修复的新型蛋白质。
Protein Sci. 2025 Apr;34(4):e70101. doi: 10.1002/pro.70101.
7
MRI detects blood-brain barrier alterations in a rat model of Alzheimer's disease and lung infection.磁共振成像(MRI)检测阿尔茨海默病和肺部感染大鼠模型中的血脑屏障改变。
Npj Imaging. 2025;3(1):8. doi: 10.1038/s44303-025-00071-5. Epub 2025 Mar 4.
8
Iron(III)-Quercetin Complex: In Vivo Acute Toxicity and Biodistribution of Novel MRI Agent.铁(III)-槲皮素复合物:新型磁共振成像剂的体内急性毒性和生物分布
Int J Nanomedicine. 2025 Jan 31;20:1303-1320. doi: 10.2147/IJN.S496015. eCollection 2025.
9
FireVoxel: Interactive Software for Multi-Modality Analysis of Dynamic Medical Images.FireVoxel:用于动态医学图像多模态分析的交互式软件。
J Imaging Inform Med. 2025 Feb 3. doi: 10.1007/s10278-025-01404-x.
10
Prognostic value of pretreatment radiological MRI variables and dynamic contrast-enhanced MRI on radiotherapy treatment outcome in laryngeal and hypopharyngeal tumors.治疗前放射学磁共振成像(MRI)变量及动态对比增强MRI对喉癌和下咽癌放射治疗结果的预后价值
Clin Transl Radiat Oncol. 2024 Sep 12;49:100857. doi: 10.1016/j.ctro.2024.100857. eCollection 2024 Nov.